e-ISSN: 2321-3647
logo

American Journal of Pharmacy and Health Research

Dr. Dhanu Josey

Author Profile
1
Publications
1
Years Active
3
Collaborators
22
Citations

Publications by Dr. Dhanu Josey

1 publication found • Active 2025-2025

2025

1 publication

Dapagliflozin Induced Severe Pruritis – A Rare Adverse Drug Reaction

with Dr. Namitha Rachel Biji, Prof. Dr. S.K Mathew, Dr. Joseph John
10/1/2025

ABSTRACTDapagliflozin is an SGLT2 inhibitor that is used to treat type 2 diabetes, as well as those with heart failure and chronic renal disease. We report a case report of a 57-year-old male diabetic who presented with severe pruritis which was later found to be due to dapagliflozin and was totally subsided after discontinuing dapagliflozin. Keyword: SGLT2 inhibitor - Selective sodium-glucose transporter-2 inhibitor.

Author Statistics
Total Publications:1
Years Active:1
First Publication:2025
Latest Publication:2025
Collaborators:3
Citations:22